CRIS Current Research Information System

RECANATINI, MAURIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.028
EU - Europa 6.088
AS - Asia 6.052
AF - Africa 421
SA - Sud America 367
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 19
Totale 20.994
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.945
SG - Singapore 1.855
CN - Cina 1.816
GB - Regno Unito 1.538
IT - Italia 1.239
VN - Vietnam 1.077
DE - Germania 801
SE - Svezia 520
UA - Ucraina 502
HK - Hong Kong 484
IN - India 360
RU - Federazione Russa 326
FR - Francia 279
BR - Brasile 274
IE - Irlanda 220
CI - Costa d'Avorio 137
NL - Olanda 118
JP - Giappone 116
EE - Estonia 102
ZA - Sudafrica 102
KR - Corea 98
TG - Togo 96
JO - Giordania 75
CH - Svizzera 64
ES - Italia 64
FI - Finlandia 61
AR - Argentina 47
CA - Canada 47
HR - Croazia 46
BG - Bulgaria 45
SC - Seychelles 40
ID - Indonesia 31
NG - Nigeria 30
BE - Belgio 29
CZ - Repubblica Ceca 27
IR - Iran 24
MX - Messico 23
PL - Polonia 22
AT - Austria 21
PK - Pakistan 19
AU - Australia 17
EU - Europa 16
TR - Turchia 15
EC - Ecuador 12
GR - Grecia 12
LT - Lituania 12
TW - Taiwan 12
BD - Bangladesh 11
MT - Malta 10
CL - Cile 9
MY - Malesia 8
PH - Filippine 8
RO - Romania 8
TH - Thailandia 8
BZ - Belize 7
CO - Colombia 7
PT - Portogallo 7
VE - Venezuela 7
IQ - Iraq 6
MA - Marocco 6
SA - Arabia Saudita 5
UZ - Uzbekistan 5
EG - Egitto 4
IL - Israele 4
LB - Libano 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AE - Emirati Arabi Uniti 3
MD - Moldavia 3
PE - Perù 3
UY - Uruguay 3
AL - Albania 2
BO - Bolivia 2
DZ - Algeria 2
LK - Sri Lanka 2
LV - Lettonia 2
NO - Norvegia 2
PY - Paraguay 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
CU - Cuba 1
GD - Grenada 1
GT - Guatemala 1
HU - Ungheria 1
KE - Kenya 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MU - Mauritius 1
NC - Nuova Caledonia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
SN - Senegal 1
SR - Suriname 1
TT - Trinidad e Tobago 1
VC - Saint Vincent e Grenadine 1
Totale 20.994
Salva come PNG Salva come JPEG
Città #
Southend 1.332
Singapore 1.182
Fairfield 868
Ashburn 731
Chandler 556
Santa Clara 511
Hong Kong 469
Seattle 416
Wilmington 410
Woodbridge 402
Houston 353
Jacksonville 339
Ann Arbor 338
Cambridge 325
Princeton 290
Hefei 278
Bologna 268
Beijing 251
Dong Ket 228
Dublin 220
Boardman 207
Hanoi 204
Ho Chi Minh City 202
Nanjing 144
Abidjan 137
Westminster 132
Padova 131
Tokyo 109
Berlin 104
Los Angeles 103
Lomé 96
Seoul 84
Milan 80
Amman 75
Buffalo 73
Jinan 72
Saint Petersburg 64
New York 60
Shenyang 57
Hebei 54
Mülheim 52
Dallas 49
Munich 45
Helsinki 44
Sofia 44
Medford 40
Redondo Beach 39
San Diego 39
Mahé 38
Bern 36
Frankfurt am Main 35
Nanchang 35
Redmond 34
São Paulo 34
Verona 34
Changsha 33
Dearborn 33
Guangzhou 32
Shanghai 32
Zhengzhou 32
Abeokuta 30
Barcelona 30
Tianjin 30
Chicago 29
Brussels 26
Hangzhou 26
Council Bluffs 25
Turin 24
Bengaluru 23
Da Nang 22
Norwalk 21
Olalla 21
Des Moines 19
Phoenix 19
Haikou 18
Jakarta 18
Ningbo 18
San Jose 18
Falkenstein 17
Leawood 17
Quận Bình Thạnh 17
Yubileyny 17
Haiphong 16
Rome 16
Harbin 15
Jiaxing 15
Falls Church 14
Florence 14
Amsterdam 13
Brno 13
Kunming 13
Lanzhou 13
Madrid 13
Modena 13
Nuremberg 13
Redwood City 13
Turku 13
Warsaw 13
Fuzhou 12
London 12
Totale 13.444
Salva come PNG Salva come JPEG
Nome #
A small molecule targeting the multifactorial nature of Alzheimer's disease 473
La metadinamica nello studio dell'energia libera di complessi recettoriali binari 263
Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation. 236
hERG-related drug toxicity and models for predicting hERG liability and QT prolongation 232
Structure-Activity Relationships and Binding Mode in the Human Acetylcholinesterase Active Site of Pseudo-Irreversible Inhibitors Related to Xanthostigmine 225
An automated docking protocol for HERG channel blockers. 225
Characterisation of bioactive compounds in wine by-products: toward the valorisation of sustainable resources 224
A molecular dynamics study of reovirus attachment protein sigma1 reveals conformational changes in sigma1 structure 214
Computational design and discovery of "minimally structured" hERG blockers. 213
Acetylcholinesterase inhibitors as starting point towards improved Alzheimer’s disease therapeutics 205
SINTESI PARALLELA DI UNA COLLEZIONE DI PICCOLE MOLECOLE SIMIL-NATURALI MEDIANTE REAZIONE DOMINO KNOEVENAGEL/ DIELS-ALDER 191
Antiproliferative agents that interfere with the cell cycle at the G(1)-->S transition: further development and characterization of a small library of stilbene-derived compounds 191
Dynamic Docking: A Paradigm Shift in Computational Drug Discovery 191
Protein Tunnels: The Case of Urease Accessory Proteins 188
Computational drug discovery under RNA times 185
Computational approaches to the study of dual-site and peripheral site binding ache inhibitors 181
Extensive SAR and computational studies of 3-{4-[(benzylmethylamino)methyl]phenyl}-6,7-dimethoxy-2H-2-chromenone (AP2238) derivatives. 181
SAR and binding mode at the h-AChE active site of pseudo-irreversible inhibitors related to Xanthostigmine 181
Lactate dehydrogenase inhibitors can reverse inflammation induced changes in colon cancer cells 181
LDH inhibition impacts on heat shock response and induces senescence of hepatocellular carcinoma cells 176
Progettazione e sintesi di derivati poliamminici per il trattamento della malattia di Alzheimer 175
Galloflavin (CAS 568-80-9), a novel inhibitor of lactate dehydrogenase. 175
AClAP, Autonomous hierarchical agglomerative Cluster Analysis based protocol to partition conformational datasets 175
Collecting and assessing human lactate dehydrogenase-A conformations for structure-based virtual screening 173
Domino Knovenaegel/Diels-Alder Sequence Coupled to Suzuki Reaction: a Powerful Synthetic Platform for Chemical Biology 170
Lactate dehydrogenase inhibitors sensitize lymphoma cells to cisplatin without enhancing the drug effects on immortalized normal lymphocytes. 170
Alpha7 nicotinic acetylcholine receptor agonists: prediction of their binding affinity through a molecular mechanics Poisson-Boltzmann surface area approach 168
A comparative study on the application of hierarchical-agglomerative clustering approaches to organize outputs of reiterated docking runs. 167
A natural-like synthetic small molecule impairs bcr-abl signaling cascades and induces megakaryocyte differentiation in erythroleukemia cells 166
Binding Residence Time through Scaled Molecular Dynamics: A Prospective Application to hDAAO Inhibitors 165
Enantioselective nonsteroidal aromatase inhibitors identified through a multidisciplinary medicinal chemistry approach 163
CHOLINESTERASE INHIBITORS: SAR AND ENZYME INHIBITORY ACTIVITY OF 3-[omega-(BENZYLMETHYLAMINO)ALKOXY]XANTHEN-9-ONES 163
Density functional study of the enzymatic reaction catalyzed by a cyclin-dependent kinase 162
Density Functional Studies on the Nazarov Reaction Involving Cyclic Systems. 162
Role of phosphorylated Thr160 for the activation of the CDK2/Cyclin A complex 162
In silico modelling--pharmacophores and hERG channel models 159
Synthesis and pharmacological profile of a series of 1-substituted-2-carbonyl derivatives of diphenidol: novel M4 muscarinic receptor antagonists 159
Domino Knoevenagel/Diels–Alder sequence coupled to Suzuki reaction: a valuable synthetic platform for chemical biology 158
Synthesis of natural urolithin M6, a galloflavin mimetic, as a potential inhibitor of lactate dehydrogenase A 158
A Computational Study of the Binding of Propidium to the Peripheral Anionic Site of Human Acetylcholinesterase 158
Targeting the Protein Tunnels of the Urease Accessory Complex: A Theoretical Investigation 157
Target-related applications of first principles quantum chemical methods in drug design 155
Novel antiproliferative chimeric compounds with marked histone deacetylase inhibitory activity. 155
Multi-Target-Directed Drug Design Strategy: From a Dual Binding Site Acetylcholinesterase Inhibitor to a Trifunctional Compound against Alzheimer's Disease 153
Lead optimization providing a series of flavone derivatives as potent nonsteroidal inhibitors of the cytochrome P450 aromatase enzyme 152
Mapping cholesterol interaction sites on serotonin transporter through coarse-grained molecular dynamics 151
Identification of a terphenyl derivative that blocks the cell cycle in the G0-G1 phase and induces differentiation in leukemia cells. 149
Derivati a struttura benzofenonica come inibitori dell'acetilcolinesterasi 148
Computational study of the phosphoryl transfer catalyzed by a cyclin-dependent kinase 148
Targeting the JAK/STAT Pathway: A Combined Ligand- And Target-Based Approach 148
The role of the peripheral anionic site and cation-pi interactions in the ligand penetration of the human AChE gorge. 145
Targeting Alzheimer’s disease: Novel indanone hybrids bearing a pharmacophoric fragment of AP2238 145
Exploring Conformational Dynamics of the Extracellular Venus flytrap Domain of the GABAB Receptor: A Path-Metadynamics Study 144
Imidazolylmethylbenzophenones as highly potent aromatase inhibitors. 142
Exploring complex protein-ligand recognition mechanisms with coarse metadynamics 142
Novel Class of Quinone-Bearing Polyamines as Multi-Target-Directed Ligands To Combat Alzheimer's Disease 141
Synthesis and conformational preferences of cyclic unnatural di- and tri-peptides containing L-Valine unit. Part 2 140
PREPARATION AND STEREOCHEMICAL CHARACTERIZATION OF ENANTIOMERIC HOMOISOFLAVONES ACTIVE AS AROMATASE INHIBITORS 139
Predicting Residence Time and Drug Unbinding Pathway through Scaled Molecular Dynamics 139
Network modeling helps to tackle the complexity of drug-disease systems 138
Memoquin: a new compound to attack Alzheimer's disease drug discovery 138
Characterization of Cholinesterase inhibitors by means of immobilized enzyme reactor 137
Multi-target-Directed Ligands To Combat Neurodegenerative Diseases 136
null 136
An unsupervised computational pipeline identifies potential repurposable drugs to treat Huntington's disease and multiple sclerosis 135
Innovative Strategy toward Mutant CFTR Rescue in Cystic Fibrosis: Design and Synthesis of Thiadiazole Inhibitors of the E3 Ligase RNF5 135
Multi-target-directed coumarin derivatives: hAChE and BAC1 inhibitors as potential anti-Alzheimer compounds 134
An Integrated Markov State Model and Path Metadynamics Approach to Characterize Drug Binding Processes 133
Memoquin: a new therapeutic poly-agent for Alzheimer's disease 131
Identification of a Terphenyl-Based Small Molecule That Induces Differentiation in Leukemia Cells 131
Heterocyclic inhibitors of AChE acylation and peripheral sites. 130
The role of Li(+), Na(+), and K(+) in the ligand binding inside the human acetylcholinesterase gorge 129
Phytoestrogens in postmenopause: the state of the art from a chemical, pharmacological and regulatory perspective 129
Conformational plasticity of kinases: molecular dynamics simulation of the conformational changes in the activation loop and the PSSARLE helix of Cdk5 128
Probing the binding sites and mechanisms of action of two human ether-a-go-go-related gene channel activators, 1,3-bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643) and 2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD307243) 128
Modeling the hERG potassium channel in a phospholipid bilayer: Molecular dynamics and drug docking studies 127
Preparation of 2,5-bis-diamine-[1,4]benzoquinone derivatives for the treatment of Alzheimer's disease and a process for their preparation and intermediates thereof. 126
Design, Synthesis, and Biological and Crystallographic Evaluation of Novel Inhibitors ofPlasmodium falciparumEnoyl-ACP-reductase (PfFabI) 126
The role of fragment-based and computational methods in polypharmacology. 126
In silico antitarget screening 126
MEMOQUIN: A MULTIPOTENT ACETYLCHOLINESTERASE INHIBITOR WITH EXCELLENT IN VIVO ACTIVITY 123
Sequential Virtual Screening Approach to the Identification of Small Organic Molecules as Potential BACE-1 Inhibitors 123
Single-molecule pulling simulations can discern active from inactive enzyme inhibitors 123
Applicazione dell'analisi statistica a studi di docking e virtual screening condotti su Cdk2 121
Cyclin-dependent kinases: bridging their structure and function through computations 121
Protein Dynamics of the HIF-2α PAS-B Domain upon Heterodimerization and Ligand Binding 121
Structure-Activity Relationships of Acetylcholinesterase Noncovalent Inhibitors Based on a Polyamine Backbone. 4. Futher Investigation on the Inner Spacer. 121
QT prolongation through hERG K(+) channel blockade: Current knowledge and strategies for the early prediction during drug development 121
QSAR and pharmacophores for drugs involved in hERG blockage 120
Probing the transport of Ni(II) ions through the internal tunnels of the Helicobacter pylori UreDFG multimeric protein complex 120
Novel 1,3-dipropyl-8-(3-benzimidazol-2-yl-methoxy-1-methylpyrazol-5-yl)xanthines as potent and selective A₂B adenosine receptor antagonists. 119
Novel highly potent and selective nonsteroidal aromatase inhibitors: synthesis, biological evaluation and structure-activity relationships investigation 119
Modeling hERG and its interactions with drugs: recent advances in light of current potassium channel simulations 118
Unveiling the Burden of Drug-Induced Impulsivity: A Network Analysis of the FDA Adverse Event Reporting System 115
Memoquin: an up-date on preclinical studies 115
Identification of biphenyl-based hybrid molecules able to decrease the intracellular level of Bcl-2 protein in Bcl-2 overexpressing leukemia cells 115
Substrate Binding Process and Mechanistic Functioning of Type 1 11beta-Hydroxysteroid Dehydrogenase from Enhanced Sampling Methods 115
Predicting reactivity and stereoselectivity in the Nazarov reaction: A combined computational and experimental study 115
Structure-Activity Relationships of New Acetylcholinesterase Noncovalent Inhibitors Based on a Polyamine Backbone 115
How dynamic docking simulations can help to tackle tough drug targets 113
Totale 15.589
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.378
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.378
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.343 0 0 0 0 0 153 61 163 184 119 136 527
2021/20222.427 266 54 186 179 223 157 71 201 102 150 401 437
2022/20232.830 272 422 165 323 178 190 75 193 517 109 211 175
2023/2024952 53 147 68 102 74 154 45 79 30 89 54 57
2024/20253.460 110 576 342 211 776 188 220 128 50 168 115 576
2025/20264.066 758 770 716 602 825 395 0 0 0 0 0 0
Totale 21.372